Omer David Keilaf - 07 Jul 2026 Form 4 Insider Report for Innoviz Technologies Ltd. (INVZ)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: INVZ
Reported as of: 07 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jul 2026, 06:01:07 UTC
Prior SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dafna Raz - Attorney-in-Fact

Key filing fact

Omer David Keilaf filed Form 4 for Innoviz Technologies Ltd. (INVZ) on 09 Jul 2026.

Key facts

This page summarizes Omer David Keilaf's Form 4 filing for Innoviz Technologies Ltd. (INVZ).
5 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 09 Jul 2026, 06:01.

Change

Previous filing in this sequence was filed on 04 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001964231 Primary reporting owner

Keilaf Omer David

Relationship: Chief Executive Officer, Director
Address: C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL
Signature: /s/ Dafna Raz - Attorney-in-Fact
Signature date: 09 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVZ transaction

Ordinary Shares

Other

Transaction value
Shares: -679,400
Change %: -19%
Price: $0.000000^*
Shares after: 2,826,531
Date: 07 Jul 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INVZ transaction Derivative

Share Option

Other

Transaction value
Shares: -510,222
Change %: -50%
Price: $0.000000^*
Shares after: 510,222
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 510,222
Exercise price: $11.50
Footnotes: F1, F4

INVZ transaction Derivative

Share Option

Other

Transaction value
Shares: -342,408
Change %: -50%
Price: $0.000000^*
Shares after: 342,408
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 342,408
Exercise price: $9.92
Footnotes: F1, F4

INVZ transaction Derivative

Share Option

Other

Transaction value
Shares: -29,240
Change %: -31%
Price: $0.000000^*
Shares after: 64,328
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 29,240
Exercise price: $5.23
Footnotes: F1, F5

INVZ transaction Derivative

Share Option

Other

Transaction value
Shares: -25,641
Change %: -22%
Price: $0.000000^*
Shares after: 91,575
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 25,641
Exercise price: $4.03
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

Footnote F2

The amount includes 916,552 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 7,798 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 62,978 RSUs granted February 27, 2024, with 10,674 vesting quarterly through 2027 and 52,304 vesting quarterly through 2028; (d) 54,531 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 75,251 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 562,500 RSUs granted May 26, 2025, vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Footnote F3

No consideration was paid in connection with the transfer. No exercise price is applicable.

Footnote F4

Immediately exercisable.

Footnote F5

Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Footnote F6

Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.